Niagen Bioscience, Inc. Common Stock (NAGE) — Analysis Summary
Niagen Bioscience, Inc. Common Stock (NAGE) has a market cap of $307.43M with year-over-year revenue growth of +29.9%. Net margin stands at 13.4%. The stock trades at a P/E ratio of 16.5.
Key Takeaways
- Revenue changed +29.9% year-over-year
- Net margin of 13.4%
- P/E ratio of 16.5
Compared to other companies in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector, NAGE posted revenue growth of +29.9% and trades at a P/E of 16.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.